Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.35 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4996746 | 0.75 | CACNA1B (0.40) | EPHX1ALDH1A1ALOX15LMNAHSD17B10 | |
| SCHEMBL9998013 | 0.75 | CACNA1B (0.40) | EPHX1ALDH1A1ALOX15LMNAHSD17B10 | |
| SCHEMBL6988173 | 0.74 | LMNA (0.35) | EPHX1ALDH1A1ALOX15LMNAHSD17B10 | |
| SCHEMBL10438900 | 0.71 | ALDH1A1 (0.35) | EPHX1ALDH1A1ALOX15LMNAHSD17B10 | |
| SCHEMBL11070169 | 0.70 | HTT (0.42) | EPHX1NAAAHTTALOX15LMNA | |
| SCHEMBL74779 | 0.70 | ALDH1A1 (0.50) | ALDH1A1ALOX15LMNAHSD17B10 | |
| SCHEMBL221749 | 0.70 | ALDH1A1 (0.50) | ALDH1A1ALOX15LMNAHSD17B10 | |
| SCHEMBL271027 | 0.70 | ALDH1A1 (0.50) | ALDH1A1ALOX15LMNAHSD17B10 | |
| SCHEMBL2470876 | 0.69 | — | — | |
| SCHEMBL15748576 | 0.69 | NAAA (0.42) | EPHX1NAAACYP19A1ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070020210-A1 | Methods of reducing the perception of body odors with olfactory adaptation and cross-adapting agents | MONELL CHEMICAL SENSES CENTER | 2007-01-25 | — | — | US | claimed |
| CN-118697922-A | Perfume dispersing device | 弗门尼舍有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-115651762-A | Alcohol with floral scent | 弗门尼舍有限公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-105873963-B | Polymer compositions comprising and releasing odorous active compounds | 阿肯马法国公司 | 2021-10-01 | — | — | CN | disclosed |
| CN-106367212-B | Liquid softener composition | 狮王株式会社 | 2021-04-20 | — | — | CN | disclosed |
| CN-105916970-B | Powdery musk odorant macrocycles | 弗门尼舍有限公司 | 2019-12-10 | — | — | CN | disclosed |
| CN-108136063-A | Perfume dispersing device | 弗门尼舍有限公司 | 2018-06-08 | — | — | CN | disclosed |
| EP-3066138-A1 | POLYMERIC COMPOSITION COMPRISING AND RELEASING AN ODORIFEROUS ACTIVE COMPOUND | Arkema France (FR) | 2016-09-14 | — | — | EP | disclosed |
| WO-2015067722-A1 | POLYMERIC COMPOSITION COMPRISING AND RELEASING AN ODORIFEROUS ACTIVE COMPOUND | ARKEMA FRANCE (FR) | 2015-05-14 | — | — | WO | disclosed |
| US-20120077722-A1 | AMBERGRIS FRAGRANCE | SYMRISE AG (DE) | 2012-03-29 | — | — | US | disclosed |
| US-8119587-B2 | Microcapsules | GIVAUDAN SA (CH) | 2012-02-21 | — | — | US | disclosed |
| EP-2111214-B1 | MICROCAPSULES | GIVAUDAN SA (CH) | 2011-04-13 | — | — | EP | disclosed |
| US-20080131389-A1 | Hair Relaxer | SHOWA DENKO K.K. (JP) | 2008-06-05 | — | — | US | disclosed |
| EP-1845940-A1 | HAIR RELAXER | Showa Denko K.K. (JP) | 2007-10-24 | — | — | EP | disclosed |
| WO-2006083031-A1 | HAIR RELAXER | SHOWA DENKO K.K. (JP) | 2006-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077722-A1 | AMBERGRIS FRAGRANCE | TRPA1, TAS2R31, TAS2R1 | EPHX1 955/4885NAAA 521/4885CYP19A1 500/4885 |
| US-20080131389-A1 | Hair Relaxer | BHMT2, BHMT, MGMT | EPHX1 2817/4885NAAA 411/4885CYP19A1 2443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.